We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boston Scientific’s $1.7 Billion Settlement Could Have ‘Chilling Effect’ on Industry
Boston Scientific’s $1.7 Billion Settlement Could Have ‘Chilling Effect’ on Industry
February 5, 2010
Boston Scientific has agreed to pay $1.7 billion to Cordis, a Johnson & Johnson (J&J) subsidiary, to settle patent disputes involving stent technology — a move that could change the way devicemakers protect their products, experts say.